What Telomir Pharmaceuticals Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 1 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 14,639,420 |
| Disposed | 0 | 0 |
| Net activity | +0 | +14,639,420 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Aminov Erez | CEO and Chairman | Apr 22 | Other Transaction · J | +7,319,710 | $1.37 | +$10M | 7,319,710 |
| Aminov Erez | CEO and Chairman | Aug 19 | Open-market sale · S | −200 | $6.20 | −$1.24K | 29,600 |
| Aminov Erez | CEO and Chairman | Aug 19 | Open-market sale · S | −200 | $6.01 | −$1.2K | 29,600 |
| Bay Shore Trust | 10% owner | Feb 13 | Open-market buy · P | +49,000 | $7.00 | +$343K | 1,902,659 |
| Bay Shore Trust | 10% owner | Feb 13 | Open-market buy · P | +40,000 | $7.00 | +$280K | 1,365,646 |
| Bay Shore Trust | 10% owner | Feb 13 | Open-market buy · P | +49,000 | $7.00 | +$343K | 5,455,431 |
Loading...
